LIFE - aTyr Pharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
10,386
10,386
0
10,455
422
Operating Expense
56,790
56,790
34,015
26,366
23,400
Operating Income
-46,404
-46,404
-34,015
-15,911
-22,978
Other Income Expense
1,061
1,061
238
-319
-785
Pretax Income
-45,343
-45,343
-33,777
-16,230
-23,763
Net Income Common Stockholders
-45,338
-45,338
-33,768
-16,224
-23,603
Diluted NI Available to Com Stockholders
-45,338
-45,338
-33,768
-16,224
-23,603
Basic EPS
-
-
-1.77
-1.77
-7.03
Diluted EPS
-
-
-1.77
-1.77
-7.03
Basic Average Shares
-
-
19,081
9,160
3,356
Diluted Average Shares
-
-
19,081
9,160
3,356
Total Operating Income as Reported
-46,404
-46,404
-34,015
-15,911
-22,978
Total Expenses
56,790
56,790
34,015
26,366
23,400
Net Income from Continuing & Discontinued Operation
-45,338
-45,338
-33,768
-16,224
-23,603
Normalized Income
-45,338
-45,338
-33,768
-16,224
-23,603
EBIT
-46,404
-46,404
-34,015
-15,911
-22,978
EBITDA
-44,709
-
-
-
-
Reconciled Depreciation
1,695
1,695
1,304
1,266
1,366
Net Income from Continuing Operation Net Minority Interest
-45,338
-45,338
-33,768
-16,224
-23,603
Normalized EBITDA
-44,709
-46,404
-32,711
-15,911
-22,978
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0

Yahoo Finance Plus Essential access required.

Learn more